Prevalence of Frailty in Patients With a Cardiovascular Disease and Correlations With Markers of Exercise

June 23, 2020 updated by: Dominique Hansen, Hasselt University

In the first part of this study the prevalence of frailty in patients with cardiovascular disease will be examined. Frailty is defined as a progressive age-related decline in physiological systems that results in decreased reserves of intrinsic capacity, which confers extreme vulnerability to stressors. Patients (≥65 years, men and women) suffering from heart failure or undergoing a coronary artery bypass grafing (CABG) or percutaneous coronary intervention (PCI) will be included. Based on the phenotype of Fried, frailty will be examined in the physical domain. Moreover, the nutritional, social, psychological and cognitive domain of frailty will be examined. This will result in a total score of 0 (no frailty) to 24 (severe frailty), divided into four categories: no frailty (score 0-6), minor frailty (score 7-12), moderate frailty (score 13-18) or severe frailty (score 18-24).

Besides this frailty protocol, a few other measurements will be completed to collect additional information about the functioning of the patient.

At discharge from the hospital, some of these patients will start with a cardiac rehabilitation program. To define the exercise intensity of this program, patients will perform a maximal exercise test (CPET). In the second part of this study, correlations will be examined between markers of frailty and markers of exercise from the CPET (e.g. maximal heart rate, maximal oxygen uptake).

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

140

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Hasselt, Limburg, Belgium, 3500
        • Jessa Hospital Campus Virga Jesse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Men and women with an age of at least 65 years at the start of the study who are admitted to Jessa Hospital Hasselt because of suffering from coronary artery diseases (with planned PCI or CABG surgery) or heart failure

Description

Inclusion Criteria:

Men and women with an age of at least 65 years at the start of the study; Staying in Jessa Hospital for PCI, CABG or heart failure

Exclusion Criteria:

A persistently unstable clinical condition at baseline visit (angina, advanced conduction disturbances, threatening ventricular arrhythmias, acute heart failure, clinical condition requiring interventions such as acute renal failure, Hb <9,0 mg/dl, presence of end-stage disease or the lack of informed consent to study participation)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of (in)dependence via the Katz scale
Time Frame: At baseline
Evaluation of the level of (in)dependence in activities of daily life via a 4-point scale (1-4)
At baseline
Nutritional status via the Mini Nutritional Assessment (MNA)
Time Frame: At baseline
Examination of the nutritional status of the patient via a questionnaire (30 points)
At baseline
Level of physical activity via the International Physical Activity Questionnaire (IPAQ)
Time Frame: At baseline
Examination of the level of physical activity of the patient via a questionnaire
At baseline
Cognitive status via the Mini Mental State Examination (MMSE)
Time Frame: At baseline
Examination of the cognitive status of the patient via a short screening (30 points)
At baseline
Psychological status via the Geriatric Depression Scale (GDS-15)
Time Frame: At baseline
Examination of the presence/absence of a depressive mood via a questionnaire (15 questions/15 points)
At baseline
Concern about falling via the Falls Efficacy Scale (FES-I)
Time Frame: At baseline
Examination of the level of concern about falling during social and physical activities via a questionnaire (16 questions/ 64 points)
At baseline
Weight loss via the evaluation of body weight
Time Frame: At baseline
Evaluation of involuntary loss of body weight in the previous months
At baseline
Gait speed via the 4.6 meter walking test
Time Frame: At baseline
Examination of the walking speed of the patient
At baseline
Evaluation of handgrip strength
Time Frame: At baseline
Evaluation of the handgrip strength of the patient via handheld dynamometry
At baseline
Examination of mobility/balance/muscle strength/risk of falling via the Timed Up and Go Test (TUG)
Time Frame: At baseline
The Timed Up and Go Test measures the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down. By combining this test with a motor or cognitive dual task, the risk of falling of the patient will be examined.
At baseline
Comorbidities via the record of medication use
Time Frame: At baseline
Record of cardiac and other medications
At baseline
Evaluation of lower limb strength
Time Frame: At baseline
Evaluation of lower limb strength of the patient via Microfet measurements
At baseline
Evaluation of functional lower limb strength
Time Frame: At baseline
Evaluation of functional lower limb strength of the patient via the Timed Chair Stand Test
At baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlations between frailty (via the primary frailty outcome measures) and exercise parameters (via the maximal exercise test (CPET)
Time Frame: At the start of the cardiac rehabilitation program
Evaluation of correlations between frailty characteristics (from the primary outcome measures) and exercise parameters from a maximal exercise test (CPET) (performed at the start of a cardiac rehabilitation program).
At the start of the cardiac rehabilitation program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2019

Primary Completion (Actual)

June 23, 2020

Study Completion (Actual)

June 23, 2020

Study Registration Dates

First Submitted

December 17, 2019

First Submitted That Met QC Criteria

December 19, 2019

First Posted (Actual)

December 20, 2019

Study Record Updates

Last Update Posted (Actual)

June 24, 2020

Last Update Submitted That Met QC Criteria

June 23, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FrCR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

3
Subscribe